トロムソー:新しいカリキュラムからの教訓

Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia.

Journal of thrombosis and haemostasis : JTH·2003

Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction.

European journal of clinical nutrition·2003

Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease.

Minerva medica·2002

[Use of statins in hospitals after myocardial infarction].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2002

n-3 polyunsaturated fatty acids and cardiovascular diseases.

Lipids·2002

[Antithrombotic treatment of atrial fibrillation in hospital].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke·2001

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Learning-centred use of generative AI and later academic functioning: a baseline-adjusted three-wave panel study.

Frontiers in psychology·2026

Acceptability and Utility of a Virtual Reality Diabetes-Related Foot Disease Training Program for First Nations People: A Pragmatic Quasi-Experimental Case Series Study.

The Australian journal of rural health·2026

Building on the 2025 National Academies Pharmacy Workshop: Clarifying Foundational and Specialization Competencies in PharmD Training.

American journal of pharmaceutical education·2026

Wellness, Resilience, and Burnout Among Pediatric Rheumatology Fellows: A Narrative Medicine Pilot Intervention.

Healthcare (Basel, Switzerland)·2026

Ready or Not? Program Directors' Preparedness for the General Pediatrics Enstrustable Professional Activity Framework.

Academic pediatrics·2026

Impact of specifications grading on a pharmacy communication and professionalism course.

Currents in pharmacy teaching & learning·2026

関連する実験動画

トロムソー:新しいカリキュラムからの教訓

関連する概念動画

Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia.

Increased lipid peroxidation during long-term intervention with high doses of n-3 fatty acids (PUFAs) following an acute myocardial infarction.

Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease.

[Use of statins in hospitals after myocardial infarction].

n-3 polyunsaturated fatty acids and cardiovascular diseases.

[Antithrombotic treatment of atrial fibrillation in hospital].

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Learning-centred use of generative AI and later academic functioning: a baseline-adjusted three-wave panel study.

Acceptability and Utility of a Virtual Reality Diabetes-Related Foot Disease Training Program for First Nations People: A Pragmatic Quasi-Experimental Case Series Study.

Building on the 2025 National Academies Pharmacy Workshop: Clarifying Foundational and Specialization Competencies in PharmD Training.

Wellness, Resilience, and Burnout Among Pediatric Rheumatology Fellows: A Narrative Medicine Pilot Intervention.

Ready or Not? Program Directors' Preparedness for the General Pediatrics Enstrustable Professional Activity Framework.

Impact of specifications grading on a pharmacy communication and professionalism course.

関連する実験動画

トロムソー:新しいカリキュラムからの教訓

関連する概念動画

関連記事